FOLD Operating Cash Flow (Statement)
Amicus Therapeutics Inc · Operating Cash Flow (Statement)
FOLD Operating Cash Flow (Statement)
Latest reported$33.15Mperiod ending
FOLD TTM Cash from Operations ($15.19M → $33.15M)
TTM operating cash flow (statement)
High-resolution chart · PNG
FOLD operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 33,145,000 | |
| 12,976,000 | |
| -45,655,000 | |
| 3,562,000 | |
| -33,891,000 | |
| -26,517,000 | |
| -41,893,000 | |
| -80,717,000 | |
| -69,091,000 | |
| -153,321,000 | |
| -126,600,000 | |
| -126,329,000 | |
| -166,575,000 | |
| -156,317,000 | |
| -168,391,000 | |
| -188,452,000 | |
| -202,491,000 | |
| -181,799,000 | |
| -200,107,000 | |
| -197,702,000 | |
| -233,290,000 | |
| -241,300,000 | |
| -254,845,000 | |
| -279,812,000 | |
| -250,416,000 | |
| -253,261,000 | |
| -330,470,000 | |
| -328,980,000 | |
| -299,955,000 | |
| -313,045,000 | |
| -230,238,000 | |
| -215,162,000 | |
| -215,485,000 | |
| -173,703,000 | |
| -164,626,000 | |
| -155,442,000 | |
| -150,534,000 | |
| -154,060,000 | |
| -134,199,000 | |
| -124,100,000 | |
| -100,139,000 | |
| -79,136,000 | |
| -73,241,000 | |
| -62,424,000 | |
| -51,669,000 | |
| -45,281,000 | |
| -43,672,000 | |
| -42,114,000 | |
| -45,794,000 | |
| -45,048,000 | |
| -38,735,000 | |
| -39,605,000 | |
| -33,744,000 | |
| -38,891,000 | |
| -44,679,000 | |
| -44,155,000 | |
| -49,422,000 | |
| -14,536,000 | |
| -12,611,000 | |
| -13,860,000 | |
| -13,983,000 | |
| -46,940,000 | |
| -47,351,000 | |
| -45,950,000 | |
| -43,371,000 | |
| -47,077,000 | |
| -43,228,000 | |
| -40,517,000 | |
| -36,863,000 | |
| 19,847,000 | |
| 21,368,000 | |
| 18,732,000 | |
| 15,192,000 |